Oncos Therapeutics

📍 Finland👥 1 employees💰 Last funded Oct 2009
Biotechnology Research🌐 oncos.com
Website LinkedIn
Oncos Therapeutics develops novel cancer therapies based on its next generation oncolytic viruses. Since the onset of our Advanced Therapy Access Program in 2007, 200 patients have undergone tailored treatment suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for our ongoing clinical development.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Oncos Therapeutics?
Oncos Therapeutics has 1 investors on record on gritt.io.
When did Oncos Therapeutics last raise funding?
The most recent investment in Oncos Therapeutics recorded on gritt.io was in October 2009.
What industry is Oncos Therapeutics in?
Oncos Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oncos Therapeutics based?
Oncos Therapeutics is headquartered in Finland.